Gossamer Bio (GOSS) Research & Development (2018 - 2026)
Gossamer Bio (GOSS) reported Research & Development of $26.41 million for Q2 2026, down 36.5% from $41.58 million a year earlier and down 38.7% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Research & Development (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gossamer Bio's Research & Development came in at $163.96 million, up 8.9% year-over-year; for FY2025, it came in at $174.09 million, up 25.7% from FY2024.
- Research & Development has a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- By year, Research & Development came in at $138.49 million in FY2024 (+2.4%), $135.3 million in FY2023 (-20.8%), $170.92 million in FY2022 (+0.4%) and $170.27 million in FY2021 (+5.9%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q1 2019.
- Year over year, Research & Development gained in seven of the last eight quarters, with growth averaging 13.9%.
- The high point for year-over-year Research & Development in five years was Q4 2025 (growth of 35.5%); the low point was Q2 2026 (a decline of 36.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $43.08 million (Q1 2026), $48.94 million (Q4 2025) and $45.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Gossamer Bio | 46.08 Mn | -427.31 Mn | - | 26.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.41 Mn |
| Mar 31, 2026 | 43.08 Mn |
| Dec 31, 2025 | 48.94 Mn |
| Sep 30, 2025 | 45.54 Mn |
| Jun 30, 2025 | 41.58 Mn |
| Mar 31, 2025 | 38.04 Mn |
| Dec 31, 2024 | 36.11 Mn |
| Sep 30, 2024 | 34.90 Mn |
| Jun 30, 2024 | 35.09 Mn |
| Mar 31, 2024 | 32.39 Mn |
| Dec 31, 2023 | 29.97 Mn |
| Sep 30, 2023 | 31.20 Mn |
| Jun 30, 2023 | 36.31 Mn |
| Mar 31, 2023 | 37.80 Mn |
| Dec 31, 2022 | 41.51 Mn |
| Sep 30, 2022 | 44.51 Mn |
| Jun 30, 2022 | 42.58 Mn |
| Mar 31, 2022 | 42.32 Mn |
| Dec 31, 2021 | 40.93 Mn |
| Sep 30, 2021 | 43.19 Mn |
API Access
Gossamer Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();